Impact of Black seed (Nigella sativa) extract on bone turnover markers in postmenopausal women with osteoporosis

Daru

Volumn 17, Issue SUPPL. 1, 2009, Pages 20-25

  Valizadeh, N ^a   Zakeri, H R ^a   Amin Asnafi, G ^a   Shafiee, A ^a   Sarkhail, P ^a   Heshmat, R ^a   Sereshti, H ^a   Larijani, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Black seed (Nigella sativa); Bone markers; Osteoporosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE BONE ISOENZYME; ALPHA THUJENE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; HEMOGLOBIN; NIGELLA SATIVA EXTRACT; OSTEOCALCIN; PHOSPHORUS; PLACEBO; THYMOQUINONE; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLACK CUMIN; BLOOD EXAMINATION; BODY MASS; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; OSSIFICATION; OSTEOLYSIS; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PILOT STUDY; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 75449103530     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Larijani B, Resh H, Aghai Meybodi HR,Mohajeri Tehrani MR. Osteoporosis in Iran, over view and Managemant, Iranian J Public Health 2007; a supplementary issue on osteoporosis: 1- 13.
2. Larijani, B., Hossein-Nezhad, A., Mojtahedi, A., Pajouhi, M., Bastanhagh, M.H., Soltani, A., Mirfezi, S.Z., Dashti, R., Normative data of bone Mineral Density in healthy population of Tehran, Iran: a cross sectional study, BMC Musculoskelet Disord, 2005 ; 6:38.
3. Tofighi, P., Hossein-Nezhad, A., Sedighi, N., Maghbooli, Z.H., Larijani, B., Vertebral geometry parameters can predict fractures, Iranian Journal of Public Health, 2007; Suppl: 14-23.
4. Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 1999 ;21(6):1025-1044. Review.
5. Roudsari, A.H., Tahbaz, F., Hossein-Nezhad, A., Arjmandi, B.,Larijani, B., Kimiagar, S.M., Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial, Nutr J, 2005 ;4:30.
6. Valizadeh N., Zakeri HR., Shafiee A., Sarkheil P., Heshmat R., Larijani B. The effect of Nigella sativa extract on biochemical bone markers in osteopenic postmenopausal women. Iranian J of Endocrin & Meta. 2009;10(6):570-580.
7. Salem ML. Immunomodulatoty and therapeutic properties of the Nigella sativa L. seed. Int 7. Immunopharmacol 2005 ; 5(13-14): 1749-1770.
8. Poorfarzib M. Clinical evaluation of antiflatulent effects of Cinnamomum zeylanicum and Nigella sativa. Dissertation (Dr. of pharmacy degree), Faculty of pharmacy.Tehran university of medical science.1373.
9. Boskabady MH, Javan H, Sajady M,Rakhshandeh H.The possible prophylactic effect of Nigella sativa seed extract in asmathic patients. Fundam Clin Pharmacol. 2007 ; 21(5): 559-566.
10. Ali BH, BLunden G, Pharmacological and toxicological properties of Nigella sativa. Phyto ther Res 10. 2003 ; 17(4) 299-305.
11. Hajhashemi V, Ghannadi A, Jafarabadi H. 11. Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res. 2004; 18(3):195-199.
12. Seibel MJ. Biochemical markers of bone turnover part ?: Clinical application in the management of osteoporosis. Clin Biochem Rev 2006; 27: 123-133.
13. Kirui PK, Cameron J, Benghuzzi HA ,Tucci M , Patel R , Adan F, et al. Effects of sustained delivery of thymoqiunone on bone healing of male rats. Biomed Sci Instrum. 2004; 40: 111-116.
14. Altan MF, Kanter M, Donmez S, Kartal ME , Buyukabs S. Combination therapy of Nigella sativa and human parathyroid hormone on bone mass,biochemical behavior and structure in streptozotocin - induced diabetic rats. Acta histochemica . 2007; 109(4): 304-314.
15. Zaoui A, Cherrah Y, Mahassini N,Alaoui K,Amarouch H,Hassar M. Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine 2002; 9(1): 69-74.
16. American Association 16. of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. AACE Osteoporosis Task Force. Endocr Pract. 2003 Nov-Dec; 9(6):544-564.
17. Tekeoglu I, Dogan A, Demirlap L. Effects of thymoquinone (volatile oil of black cumin ) on rheumatoid arthritis in rat models.Phytother Res 2006 ;20(10):869-871.
18. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008; 22(3):659-61. Epub 2007 Oct 17.
19. Black cumin seed extract.Available from http://www.answers.com/topic/ black-cumin-seed-extract?cat=health access Jan 2008.
20. Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS. The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J Ethnopharmacol. 2004; 94(2-3):251-259.
21. Riggs BL, Khosla S, Melton LJ 3rd. 21. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res. 1998; 13(5):763-773.